Edmond de Rothschild Holding’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.88M | Hold |
9,910
| – | – | 0.02% | 247 |
|
|
2026
Q1 | $1.67M | Sell |
9,910
-955
| -9% | -$163K | 0.02% | 248 |
|
|
2025
Q4 | $1.83M | Buy |
10,865
+955
| +10% | +$155K | 0.03% | 247 |
|
|
2025
Q3 | $1.43M | Hold |
9,910
| – | – | 0.02% | 272 |
|
|
2025
Q2 | $1.25M | Hold |
9,910
| – | – | 0.02% | 263 |
|
|
2025
Q1 | $1.27M | Buy |
9,910
+4,020
| +68% | +$545K | 0.02% | 253 |
|
|
2024
Q4 | $779K | Buy |
5,890
+5,090
| +636% | +$716K | 0.01% | 295 |
|
|
2024
Q3 | $116K | Sell |
800
-400
| -33% | -$57.9K | ﹤0.01% | 462 |
|
|
2024
Q2 | $165K | Hold |
1,200
| – | – | ﹤0.01% | 447 |
|
|
2024
Q1 | $165K | Hold |
1,200
| – | – | ﹤0.01% | 442 |
|
|
2023
Q4 | $163K | Sell |
1,200
-375
| -24% | -$45.8K | ﹤0.01% | 451 |
|
|
2023
Q3 | $193K | Sell |
1,575
-575
| -27% | -$73.1K | ﹤0.01% | 426 |
|
|
2023
Q2 | $273K | Hold |
2,150
| – | – | 0.01% | 415 |
|
|
2023
Q1 | $278K | Sell |
2,150
-1,995
| -48% | -$261K | 0.01% | 411 |
|
|
2022
Q4 | $544K | Buy |
4,145
+145
| +4% | +$18.7K | 0.01% | 368 |
|
|
2022
Q3 | $468K | Hold |
4,000
| – | – | 0.01% | 375 |
|
|
2022
Q2 | $470K | Sell |
4,000
-180
| -4% | -$21.4K | 0.01% | 394 |
|
|
2022
Q1 | $544K | Hold |
4,180
| – | – | 0.01% | 375 |
|
|
2021
Q4 | $638K | Sell |
4,180
-3,660
| -47% | -$567K | 0.01% | 395 |
|
|
2021
Q3 | $1.27M | Sell |
7,840
-120
| -2% | -$20.2K | 0.03% | 343 |
|
|
2021
Q2 | $1.3M | Buy |
7,960
+1,304
| +20% | +$201K | 0.03% | 331 |
|
|
2021
Q1 | $1M | Sell |
6,656
-290
| -4% | -$46.1K | 0.03% | 326 |
|
|
2020
Q4 | $1.05M | Sell |
6,946
-39,750
| -85% | -$5.68M | 0.04% | 286 |
|
|
2020
Q3 | $6.32M | Buy |
46,696
+2,874
| +7% | +$390K | 0.25% | 105 |
|
|
2020
Q2 | $5.99M | Buy |
43,822
+35,304
| +414% | +$4.5M | 0.25% | 114 |
|
|
2020
Q1 | $918K | Sell |
8,518
-225
| -3% | -$25.9K | 0.05% | 220 |
|
|
2019
Q4 | $1.05M | Buy |
8,743
+910
| +12% | +$102K | 0.04% | 240 |
|
|
2019
Q3 | $780K | Hold |
7,833
| – | – | 0.03% | 270 |
|
|
2019
Q2 | $854K | Sell |
7,833
-1,257
| -14% | -$134K | 0.03% | 251 |
|
|
2019
Q1 | $1.02M | Sell |
9,090
-2,165
| -19% | -$237K | 0.04% | 237 |
|
|
2018
Q4 | $1.08M | Sell |
11,255
-850
| -7% | -$90.2K | 0.04% | 232 |
|
|
2018
Q3 | $1.48M | Sell |
12,105
-7,465
| -38% | -$879K | 0.04% | 231 |
|
|
2018
Q2 | $2.15M | Sell |
19,570
-3,744
| -16% | -$400K | 0.06% | 203 |
|
|
2018
Q1 | $2.49M | Buy |
23,314
+1,374
| +6% | +$152K | 0.07% | 189 |
|
|
2017
Q4 | $2.34M | Buy |
21,940
+5,899
| +37% | +$631K | 0.07% | 186 |
|
|
2017
Q3 | $1.78M | Buy |
16,041
+14,916
| +1,326% | +$1.59M | 0.05% | 212 |
|
|
2017
Q2 | $116K | Buy |
1,125
+465
| +70% | +$45.8K | ﹤0.01% | 540 |
|
|
2017
Q1 | $64K | Sell |
660
-2,160
| -77% | -$207K | ﹤0.01% | 619 |
|
|
2016
Q4 | $250K | Buy |
2,820
+1,620
| +135% | +$147K | 0.01% | 464 |
|
|
2016
Q3 | $116K | Sell |
1,200
-270
| -18% | -$25.7K | ﹤0.01% | 571 |
|
|
2016
Q2 | $126K | Buy |
1,470
+60
| +4% | +$5.38K | ﹤0.01% | 539 |
|
|
2016
Q1 | $123K | Buy |
1,410
+480
| +52% | +$42.9K | ﹤0.01% | 531 |
|
|
2015
Q4 | $105K | Hold |
930
| – | – | ﹤0.01% | 546 |
|
|
2015
Q3 | $94K | Buy |
930
+630
| +210% | +$75.6K | ﹤0.01% | 554 |
|
|
2015
Q2 | $37K | Buy |
+300
| New | +$35.9K | ﹤0.01% | 673 |
|
Other funds holding IBB
CB
Edmond de Rothschild Holding's IBB Position: Q2 2026 in Review
Edmond de Rothschild Holding held its iShares Biotechnology ETF (IBB) position steady in Q2 2026 at 9,910 shares worth $1.88M. The position accounts for 0.02% of the portfolio, ranked #247.
Edmond de Rothschild Holding first reported a position in IBB in Q2 2015 and has held it in 45 quarters since. The position peaked at $6.32M in Q3 2020. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.
- Edmond de Rothschild Holding held 9,910 shares of iShares Biotechnology ETF worth $1.88M as of Q2 2026.
- Edmond de Rothschild Holding left its iShares Biotechnology ETF share count unchanged in Q2 2026.
- iShares Biotechnology ETF made up 0.02% of Edmond de Rothschild Holding's portfolio in Q2 2026, its #247 holding.
- Edmond de Rothschild Holding first reported a position in iShares Biotechnology ETF in Q2 2015 and has held it in 45 quarters since.
- Edmond de Rothschild Holding's iShares Biotechnology ETF position peaked at $6.32M in Q3 2020.
- 954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.
Based on Edmond de Rothschild Holding's 13F filing for Q2 2026, filed 10 Aug 2026.